Why moderate risk: High debt: 5.6x equity; 5 offering filings in 6 months (may sell new shares).
From GMRS's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
Last 12 months: $5.8B.
Move the sliders to your own view of GMRS. Starting points are the company's recent numbers.
What today's price needs: with a 3% margin and a 15x P/E, sales could shrink about 24% a year for 5 years and still match today's price.
Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.
Price chart by TradingView.
No open-market insider buys or sells in the last 90 days.
No trades to chart yet.
SEC filings of any kind. 50 means a normal week.
Institutions held almost none of it the quarter before (new listing, spin-off or ticker change), so there's no fair percent change yet. 61 bought, 0 sold.
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
251,882 shares at $12.20 · $3.1M
23,687 shares at $12.20 · $289K
92,680 shares at $12.20 · $1.1M
1,457,102 shares at $12.20 · $17.8M
265,794 shares at $12.20 · $3.2M
262,278 shares at $12.20 · $3.2M
Source: SEC EDGAR filings. For informational purposes. Not investment advice.
Report a problem with this page